245 related articles for article (PubMed ID: 15949505)
1. Reduction of brain volume in MS. MRI and pathology findings.
Lycklama à Nijeholt GJ
J Neurol Sci; 2005 Jun; 233(1-2):199-202. PubMed ID: 15949505
[TBL] [Abstract][Full Text] [Related]
2. Clinical-magnetic resonance imaging correlations in multiple sclerosis.
Zivadinov R; Leist TP
J Neuroimaging; 2005; 15(4 Suppl):10S-21S. PubMed ID: 16385015
[TBL] [Abstract][Full Text] [Related]
3. Measurement of brain and spinal cord atrophy by magnetic resonance imaging as a tool to monitor multiple sclerosis.
Bakshi R; Dandamudi VS; Neema M; De C; Bermel RA
J Neuroimaging; 2005; 15(4 Suppl):30S-45S. PubMed ID: 16385017
[TBL] [Abstract][Full Text] [Related]
4. In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study.
Agosta F; Absinta M; Sormani MP; Ghezzi A; Bertolotto A; Montanari E; Comi G; Filippi M
Brain; 2007 Aug; 130(Pt 8):2211-9. PubMed ID: 17535835
[TBL] [Abstract][Full Text] [Related]
5. Measurement of whole-brain atrophy in multiple sclerosis.
Pelletier D; Garrison K; Henry R
J Neuroimaging; 2004 Jul; 14(3 Suppl):11S-19S. PubMed ID: 15228755
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance imaging advances in multiple sclerosis.
Bakshi R
J Neuroimaging; 2005; 15(4 Suppl):5S-9S. PubMed ID: 16385014
[TBL] [Abstract][Full Text] [Related]
7. Spinal cord imaging in multiple sclerosis.
Tench CR; Morgan PS; Jaspan T; Auer DP; Constantinescu CS
J Neuroimaging; 2005; 15(4 Suppl):94S-102S. PubMed ID: 16385022
[TBL] [Abstract][Full Text] [Related]
8. Measuring brain atrophy in multiple sclerosis.
De Stefano N; Battaglini M; Smith SM
J Neuroimaging; 2007 Apr; 17 Suppl 1():10S-15S. PubMed ID: 17425728
[TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance imaging monitoring of multiple sclerosis lesion evolution.
Inglese M; Grossman RI; Filippi M
J Neuroimaging; 2005; 15(4 Suppl):22S-29S. PubMed ID: 16385016
[TBL] [Abstract][Full Text] [Related]
10. Contribution of white matter lesions to gray matter atrophy in multiple sclerosis: evidence from voxel-based analysis of T1 lesions in the visual pathway.
Sepulcre J; Goñi J; Masdeu JC; Bejarano B; Vélez de Mendizábal N; Toledo JB; Villoslada P
Arch Neurol; 2009 Feb; 66(2):173-9. PubMed ID: 19204153
[TBL] [Abstract][Full Text] [Related]
11. Pathogenesis of brain and spinal cord atrophy in multiple sclerosis.
Minagar A; Toledo EG; Alexander JS; Kelley RE
J Neuroimaging; 2004 Jul; 14(3 Suppl):5S-10S. PubMed ID: 15228754
[TBL] [Abstract][Full Text] [Related]
12. Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis.
Gordon-Lipkin E; Chodkowski B; Reich DS; Smith SA; Pulicken M; Balcer LJ; Frohman EM; Cutter G; Calabresi PA
Neurology; 2007 Oct; 69(16):1603-9. PubMed ID: 17938370
[TBL] [Abstract][Full Text] [Related]
13. Measurement of spinal cord atrophy in multiple sclerosis.
Lin X; Tench CR; Evangelou N; Jaspan T; Constantinescu CS
J Neuroimaging; 2004 Jul; 14(3 Suppl):20S-26S. PubMed ID: 15228756
[TBL] [Abstract][Full Text] [Related]
14. Seeing is believing: in vivo evolution of multiple sclerosis pathology with magnetic resonance.
Ge Y
Top Magn Reson Imaging; 2006 Aug; 17(4):295-306. PubMed ID: 17415002
[TBL] [Abstract][Full Text] [Related]
15. Impact of disease-modifying therapies on brain and spinal cord atrophy in multiple sclerosis.
Rudick RA
J Neuroimaging; 2004 Jul; 14(3 Suppl):54S-64S. PubMed ID: 15228760
[TBL] [Abstract][Full Text] [Related]
16. Gray matter atrophy in multiple sclerosis: a longitudinal study.
Fisher E; Lee JC; Nakamura K; Rudick RA
Ann Neurol; 2008 Sep; 64(3):255-65. PubMed ID: 18661561
[TBL] [Abstract][Full Text] [Related]
17. MRI markers of destructive pathology in multiple sclerosis-related cognitive dysfunction.
Rovaris M; Comi G; Filippi M
J Neurol Sci; 2006 Jun; 245(1-2):111-6. PubMed ID: 16626748
[TBL] [Abstract][Full Text] [Related]
18. Pathological study of spinal cord atrophy in multiple sclerosis suggests limited role of local lesions.
Evangelou N; DeLuca GC; Owens T; Esiri MM
Brain; 2005 Jan; 128(Pt 1):29-34. PubMed ID: 15548559
[TBL] [Abstract][Full Text] [Related]
19. Brain atrophy assessment in multiple sclerosis: importance and limitations.
Giorgio A; Battaglini M; Smith SM; De Stefano N
Neuroimaging Clin N Am; 2008 Nov; 18(4):675-86, xi. PubMed ID: 19068408
[TBL] [Abstract][Full Text] [Related]
20. Motor evoked potential: a reliable and objective measure to document the functional consequences of multiple sclerosis? Relation to disability and MRI.
Kalkers NF; Strijers RL; Jasperse MM; Neacsu V; Geurts JJ; Barkhof F; Polman CH; Stam CJ
Clin Neurophysiol; 2007 Jun; 118(6):1332-40. PubMed ID: 17398151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
